Syndax Pharmaceuticals, Inc. (SNDX) Q2 2023 Earnings Call Transcript

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET

Company Participants

Sharon Klahre – Head, IR

Michael Metzger – CEO

Neil Gallagher – President & Head, R&D

Keith Goldan – CFO

Peter Ordentlich – CSO

Anjali Ganguli – CBO

Conference Call Participants

Phil Nadeau – TD Cowen

Anupam Rama – JPMorgan

Ashiq Mubarack – Citi

Brad Canino – Stifel

Michael Schmidt – Guggenheim

Peter Lawson – Barclays

William Wood – B. Riley Securities

Justin Zelin – BTIG


Good day, everyone, and welcome to the Syndax Second Quarter 2023 Earnings Conference Call. Today’s call is being recorded.

At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals. Please go ahead.

Sharon Klahre

Thank you, Operator. Welcome, and thank you all for joining us today for a review of Syndax’s second quarter 2023 financial and operating results. I’m Sharon Klahre, and with me this afternoon to provide an update on the Company’s progress and discuss financial results are Michael Metzger, Chief Executive Officer; Dr. Neil Gallagher, President and Head of R&D; and Keith Goldan, Chief Financial Officer. Also joining us on the call today for the question-and-answer session are Dr. Peter Ordentlich, Chief Scientific Officer; and Dr. Anjali Ganguli, Chief Business Officer.

This call is accompanied by a slide deck that has been posted on the Investors page of the Company’s website.

You can now turn to our forward-looking statements on Slide 2. Before we begin, I’d like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of various important

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *